In the current climate autologous stem cell transplants should not be carried out except in clinical high risk disease, when a judgement should be made about the risk of progression without transplant, new guidance states. The advice is included in a suite of myeloma management recommendations issued by the UK Myeloma Forum in response to the inevitable ...
Guidance on managing myeloma patients during COVID-19
By Nicola Garrett
2 Apr 2020